Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-16 · accession 0001159036-26-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-17 | 2026-02-16 | HALO | LaBrosse Nicole | SVP, CFO | F - Tax | $79.44 | -12.9K | 26.9K | -32% | -$1.02M |
| DM | 2026-02-17 | 2026-02-16 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | +23.8K | 29.8K | +397% | $0 |
| DM | 2026-02-17 | 2026-02-16 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | -23.8K | 5,329 | -82% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-16 | F | D | 2,747 | $79.44 | 24,425 | D | — | — | (F1) The reported disposition of 2,747 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 2 | Common | Common Stock | 2026-02-16 | M | A | 13,351 | $0.00 | 40,231 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-16 | M | A | 5,093 | $0.00 | 27,172 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-16 | F | D | 7,273 | $79.44 | 32,958 | D | — | — | (F3) The reported disposition of 7,273 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 5 | Common | Common Stock | 2026-02-16 | M | A | 5,329 | $0.00 | 29,754 | D | — | — | |
| 6 | Common | Common Stock | 2026-02-16 | F | D | 2,874 | $79.44 | 26,880 | D | — | — | (F2) The reported disposition of 2,874 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 7 | Derivative | Restricted Stock Units | 2026-02-16 | M | D | 5,093 | $0.00 | 0 | D | $0.00 · — to — | 5,093 Common Stock | (F4) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 8 | Derivative | Performance Stock Units | 2026-02-16 | M | D | 13,351 | $0.00 | 0 | D | $0.00 · — to — | 13,351 Common Stock | (F5) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |
| 9 | Derivative | Restricted Stock Units | 2026-02-16 | M | D | 5,329 | $0.00 | 5,329 | D | $0.00 · — to — | 5,329 Common Stock | (F4) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |